Retiring Soon? How to Beat Your Biggest Money Fears
Is 'Good Debt' Ruining Your Chance of Retiring?
How to Have a Successful Money Talk With Your Significant Other
Taper Tantrum: Fed's Stimulus Rollback Just Not a Big Deal Anymore
Johnson & Johnson
View this photo on glassdoor.com
Two ways to beam your diabetes data to your smartphone
What Is Johnson & Johnson's Opportunity In Hepatitis C Market?
Johnson & Johnson Taps UK Research Hubs In Drive To Discover New Drugs
Alzheimer's Stocks Are a Stealth Opportunity
J&J Fined 10.8 Million Euros by EU Over Dutch Pay-to-Delay Deal
A Small-Cap Dividend Growth Stock With A 4.5% Yield To Consider
Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers
Decision Diagnostics' Board Votes to Uplist to OTC QX
Healthcare Companies Report Stock Price Updates, and Medical System Integration - Research Report on Johnson & Johnson, Geron, Ligand Pharmaceuticals, Masimo, and Capital Senior Living